Literature DB >> 20047264

Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD.

Marcin Golec1, Christian Reichel, Barbara Mackiewicz, Czeslawa Skorska, Katarzyna Curzytek, Marta Lemieszek, Jacek Dutkiewicz, Anna Gora, Rolf Ziesche, Jolanta Boltuc, Katarzyna Sodolska, Janusz Milanowski, Radoslaw Spiewak.   

Abstract

The cathelicidin LL-37 is an antimicrobial and lipopolysaccharide neutralizing peptide, possessing pro-inflammatory, tissue repair and remodeling activities. Recent reports indicate that the progression of COPD might be connected with increased levels of LL-37. The numerous experimental data show the potential role of LL-37 in the response to the exposure to organic dust (containing lipopolysaccharide and microorganisms) which is one of the major COPD causative factors. This work strives to further prove the role of LL-37 in the development of COPD. A cross-sectional study was conducted in 30 farmers in the early stages of COPD according to GOLD, 36 healthy farmers and 16 healthy urban dwellers. Collection of induced-sputum samples and lung function testing were conducted before and after work. The quantification of the LL-37 in sputum samples was performed by mass spectrometry and radioisotope techniques. Levels of granzymes A and B, IL-8, IFN-gamma and TGF-beta1 in sputum were measured by ELISA technique. Statistical analysis was conducted by Kruskal-Wallis and Mann-Whitney U tests. Significantly higher levels of LL-37 were observed in sputum samples from farmers with COPD compared to healthy individuals. The concentration of LL-37 in sputum from farmers was significantly higher compared to urban dwellers. The same was true for both granzymes A and B. The results of this study suggest that LL-37 and granzymes A and B may add to the development of COPD. The results suggest also their role in an organism's response to organic dust exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20047264

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  9 in total

1.  LL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary disease.

Authors:  Congcong Sun; Maoxiang Zhu; Zhihua Yang; Xiujie Pan; Yuke Zhang; Qin Wang; Wei Xiao
Journal:  Lab Invest       Date:  2014-06-23       Impact factor: 5.662

2.  LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs.

Authors:  Yvonne Lai; Sreedevi Adhikarakunnathu; Kanchan Bhardwaj; C T Ranjith-Kumar; Yahong Wen; Jarrat L Jordan; Linda H Wu; Bogdan Dragnea; Lani San Mateo; C Cheng Kao
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

Review 3.  Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.

Authors:  Virginia De Rose; Kevin Molloy; Sophie Gohy; Charles Pilette; Catherine M Greene
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

4.  Evaluation of plasma antimicrobial peptide LL-37 and nuclear factor-kappaB levels in stable chronic obstructive pulmonary disease.

Authors:  Pelin Uysal; Gonul Simsek; Sinem Durmus; Volkan Sozer; Hulya Aksan; Sibel Yurt; Caglar Cuhadaroglu; Filiz Kosar; Remise Gelisgen; Hafize Uzun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-01-25

5.  Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats.

Authors:  Jian-Zhen Weng; Yan Wang; Tie-Ying Sun
Journal:  Chin Med J (Engl)       Date:  2019-03-05       Impact factor: 2.628

Review 6.  Cellular stress responses and dysfunctional Mitochondrial-cellular senescence, and therapeutics in chronic respiratory diseases.

Authors:  Marko Manevski; Thivanka Muthumalage; Dinesh Devadoss; Isaac K Sundar; Qixin Wang; Kameshwar P Singh; Hoshang J Unwalla; Hitendra S Chand; Irfan Rahman
Journal:  Redox Biol       Date:  2020-01-25       Impact factor: 11.799

7.  Cathelicidin induces epithelial-mesenchymal transition to promote airway remodeling in smoking-related chronic obstructive pulmonary disease.

Authors:  Zhiming Jiang; Yuke Zhang; Yibing Zhu; Chong Li; Lei Zhou; Xiaolin Li; Fuxiang Zhang; Xianming Qiu; Yiqing Qu
Journal:  Ann Transl Med       Date:  2021-02

Review 8.  A Scoping Analysis of Cathelicidin in Response to Organic Dust Exposure and Related Chronic Lung Illnesses.

Authors:  Marcin Golec; Marta Kinga Lemieszek; Jacek Dutkiewicz; Janusz Milanowski; Sandra Barteit
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

9.  A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort.

Authors:  Allison A Lambert; Gregory D Kirk; Jacquie Astemborski; Enid R Neptune; Shruti H Mehta; Robert A Wise; M Bradley Drummond
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.